Concepedia
Statistics
Publications
6
Citations
171
H-Index
Active since
2014
Affiliations
Hôpital Saint-Louis(Current)
Inserm
Université Paris Cité
Innate Pharma (France)
Assistance Publique – Hôpitaux de Paris
Nicolas Thonnart is an author at Hôpital Saint-Louis specializing in tumor microenvironment, radiation oncology, and cell death.
Top concepts
MedicineApoptosisPathologyCell DeathCell BiologyCell SignalingCancer ResearchRadiation OncologyTumor Microenvironment
Publications per year
2014–2022
IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma
Anne Marie‐Cardine, Nicolas Viaud, Nicolas Thonnart et al. · Cancer Research · 2014 · 73 citations
Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome
Charlotte Hurabielle, Nicolas Thonnart, C. Ram‐Wolff et al. · Clinical Cancer Research · 2017 · 49 citations
KIR3DL2/CpG ODN Interaction Mediates Sézary Syndrome Malignant T Cell Apoptosis
Bouchra Ghazi, Nicolas Thonnart, M. Bagot et al. · Journal of Investigative Dermatology · 2014 · 16 citations · Full text
Oncogenic Agent, Receptor Tyrosine Kinase, Apoptosis +10
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma
Marie-Léa Gauci, Jérôme Giustiniani, C. Lepelletier et al. · Cancer Immunology Immunotherapy · 2022 · 13 citations · Full text
Phase I Study of IPH4102, Anti‐KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T‐Cell Lymphomas (CTCL): Dose‐escalation Safety, Biomarker and Clinical Activity Results
M. Bagot, Pierluigi Porcu, C. Ram‐Wolff et al. · Hematological Oncology · 2017 · 10 citations · Full text
1–5 of 6